Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients
Public ClinicalTrials.gov record NCT04590586. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Industry Alliance Platform Trial to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the time to confirmed clinical recovery in participants hospitalized with COVID-19. Candidate agents will be evaluated frequently for efficacy and safety, with candidate agents being added to and/or removed from the study on an ongoing basis, depending on the results of their evaluation.
Study identification
- NCT ID
- NCT04590586
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 515 participants
Conditions and interventions
Conditions
Interventions
- Standard of care Drug
- Apremilast Drug
- Apremilast placebo Drug
- Lanadelumab Drug
- Lanadelumab placebo Drug
- Zilucoplan Drug
- Zilucoplan placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 23, 2020
- Primary completion
- Aug 2, 2021
- Completion
- Aug 2, 2021
- Last update posted
- Jun 28, 2022
2020 – 2021
United States locations
- U.S. sites
- 21
- U.S. states
- 10
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Research Group LLC | Anniston | Alabama | 36207 | — |
| Good Samaritan Hospital | Bakersfield | California | 93309 | — |
| Sharp Chula Vista Medical Center | Chula Vista | California | 91910 | — |
| El Centro Regional Medical Center | El Centro | California | 92243 | — |
| University of California Irvine Medical Center | Orange | California | 92868 | — |
| Riverside Community Hospital | Riverside | California | 92501-4135 | — |
| University of California Davis Health System | Sacramento | California | 95817 | — |
| National Institute of Clinical Research | South El Monte | California | 91733 | — |
| UF Health Shands Hospital | Gainesville | Florida | 32610 | — |
| Memorial Hospital Jacksonville | Jacksonville | Florida | 32216 | — |
| Grady Health System | Atlanta | Georgia | 30303 | — |
| Great Lakes Clinical Trials | Chicago | Illinois | 60640 | — |
| The University of Iowa | Iowa City | Iowa | 52242 | — |
| Harper University Hospital | Detroit | Michigan | 48201-2018 | — |
| Sinai Grace Hospital | Detroit | Michigan | 48235 | — |
| Detroit Receiving Hospital | Royal Oak | Michigan | 48073 | — |
| University of Tennessee Health Sciences Center | Memphis | Tennessee | 38103 | — |
| Medical City Ft. Worth | Fort Worth | Texas | 76104 | — |
| University of Texas Health Science Center at Houston | Houston | Texas | 77030 | — |
| Texoma Medical Center | Sherman | Texas | 75090 | — |
| MultiCare Health System Institute for Research and Innovation | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04590586, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2022 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04590586 live on ClinicalTrials.gov.